Related Experiment Videos
Renal assist device therapy for acute renal failure
Susan M Dirkes1, Charles Kozlowski
1Surgical Intensive Care Unit, University of Michigan Hospitals, USA.
Summary
Acute renal failure (ARF) is common in critically ill patients. A new Renal Assist Device (RAD) aims to restore kidney functions beyond current treatments like hemodialysis.
Area of Science:
- Nephrology
- Biomedical Engineering
Background:
- Acute renal failure (ARF) is a frequent syndrome in intensive care unit (ICU) patients.
- Current renal replacement therapies (RRTs) like hemodialysis offer limited kidney function replacement.
- Existing RRTs do not fully restore metabolic, immunologic, or endocrine kidney functions.
Purpose of the Study:
- To describe the syndrome of acute renal failure (ARF).
- To introduce the Renal Assist Device (RAD), a novel bioartificial kidney.
- To discuss the application of the RAD in critically ill patients with ARF.
Main Methods:
- The article reviews the clinical syndrome of ARF.
- It describes the technology and function of the Renal Assist Device (RAD).
- Clinical trial data on RAD use in ARF patients is discussed.
Main Results:
- The Renal Assist Device (RAD) is a bioartificial kidney designed for ARF.
- RAD aims to provide more comprehensive kidney function replacement than traditional RRTs.
- The device is currently undergoing clinical trials in critically ill ARF patients.
Conclusions:
- The Renal Assist Device (RAD) represents a potential advancement in ARF treatment.
- RAD may offer more complete restoration of kidney functions compared to current therapies.
- Further clinical evaluation of RAD in ARF is ongoing.